药明康德将于3月17日审议年度业绩及股息策略

财中社
03 Mar

  3月3日,药明康德(603259/02359)发布公告,将于2025年3月17日召开董事会会议,主要内容包括考虑和批准截至2024年12月31日的年度业绩及建议的末期股息(如有)。

  公告并未透露具体的财务数据或业绩变化,因此无法提供相关的数字信息。

  此次董事会会议的召开旨在审议公司整体的经营情况及未来的股东回报策略。公告中提及的董事会成员包括执行董事和独立非执行董事,但未涉及其他具体的财务指标或经营成果的详细说明。

  2024年前三季度,药明康德实现收入277.02亿元,归母净利润65.33亿元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10